Immunological role of TAM receptors in the cancer microenvironment
- 1 January 2020
- book chapter
- Published by Elsevier
- Vol. 357, 57-79
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- MerTK inhibition in tumor leukocytes decreases tumor growth and metastasisJournal of Clinical Investigation, 2013
- MERTK receptor tyrosine kinase is a therapeutic target in melanomaJournal of Clinical Investigation, 2013
- In search of a novel target — Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Shedding of the Mer Tyrosine Kinase Receptor Is Mediated by ADAM17 Protein through a Pathway Involving Reactive Oxygen Species, Protein Kinase Cδ, and p38 Mitogen-activated Protein Kinase (MAPK)Journal of Biological Chemistry, 2011
- TAM receptors and the clearance of apoptotic cellsAnnals of the New York Academy of Sciences, 2010
- Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXRImmunity, 2009
- Immunobiology of the TAM receptorsNature Reviews Immunology, 2008
- TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling, and Potential Therapeutic Targeting in Human Cancer2008
- A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregationBlood, 2006
- Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survivalProceedings of the National Academy of Sciences, 2006